ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca2+-NFATc1 and Cav-1 signaling pathways

Zou, Binhua; Zheng, Jiehuang; Deng, Wende; Tan, Yanhui; Jie, Ligang; Qu, Yuan; Yang, Qin; Ke, Minhong; Ding, Zongbao; Chen, Yan; Yu, Qinghong*; Li, Xiaojuan*南方医科大学
PHYTOMEDICINE2021-1DOI: 10.1016/j.phymed.2020.153377
20被引8阅读
引用收藏
分享

摘要

Background: Osteoporosis is a threat to aged people who have excessive osteoclast activation and bone resorption, subsequently causing fracture and even disability. Inhibiting osteoclast differentiation and absorptive functions has become an efficient approach to treat osteoporosis, but osteoclast-targeting inhibitors available clinically remain rare. Kirenol (Kir), a bioactive diterpenoid derived from an antirheumatic Chinese herbal medicine Herba Siegesbeckiae, can treat collagen-induced arthritis in vivo and promote osteoblast differentiation in vitro, while the effects of Kir on osteoclasts are still unclear. @@@ Purpose: We explore the role of Kir on RANKL-induced osteoclastogenesis in vitro and bone loss in vivo. @@@ Methods: The in vitro effects of Kir on osteoclast differentiation, bone resorption and the underlying mechanisms were evaluated with bone marrow-derived macrophages (BMMs). In vivo experiments were performed using an ovariectomy (OVX)-induced osteoporosis model. @@@ Results: We found that Kir remarkably inhibited osteoclast generation and bone resorption in vitro. Mechanistically, Kir significantly inhibited F-actinring formation and repressed RANKL-induced NF-KB p65 activation and pp38, p-ERK and c-Fos expression. Moreover, Kir inhibited both the expression and nuclear translocation of NFATc1. Ca2+ oscillation and caveolin-1 (Cav-1) were also reduced by Kir during osteoclastogenesis in vitro. Consistent with these findings, 2-10 mg/kg Kir attenuated OVX-induced osteoporosis in vivo as evidenced by decreased osteoclast numbers and downregulated Cav-1 and NFATc1 expression. @@@ Conclusions: Kir suppresses osteoclastogenesis and the Cav-1/NFATc1 signaling pathway both in vitro and in vivo and protects against OVX-induced osteoporosis. Our findings reveal Kir as a potential safe oral treatment for osteoporosis.

学科与关键词

关键词
KirenolOsteoclastNFATc1Cav-1Osteoporosis
相关
加载中…
  • Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways
    Wang, Gang; Ma, Chao; Chen, Kai; Wang, Ziyi; Qiu, Heng; Chen, Delong; He, Jianbo; Zhang, Cheng; Guo, Ding; Lai, Boyong; Zhang, Shuangxiao; Huang, Linfeng; Yang, Fan; Yuan, Jinbo; Chen, Leilei*; He, Wei*; Xu, Jiake*Frontiers in Pharmacology, 2022, 12: 810322.被引 13
  • A Novel RANKL-Targeted Furoquinoline Alkaloid Ameliorates Bone Loss in Ovariectomized Osteoporosis through Inhibiting the NF-κB Signal Pathway and Reducing Reactive Oxygen Species
    Wong, Puiian; Lv, Zheng; Li, Jinglan; Wei, Qiushi; Xu, LiangLiang*; Fang, Bin*; Luo, Yiwen*; He, Mincong*Oxidative Medicine and Cellular Longevity, 2022, 2022: 5982014.被引 6
  • A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
    Hong, Guoju; Chen, Zhenqiu; Han, Xiaorui; Zhou, Lin; Pang, Fengxiang; Wu, Rishana; Shen, Yingshan; He, Xiaoming; Hong, Zhinan; Li, Ziqi; He, Wei; Wei, Qiushi*Clinical and Translational Medicine, 2021, 11(5): e392.被引 31
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2021-01
卷期
第 80 卷
页码
153377
DOI
10.1016/j.phymed.2020.153377
语言
GERMAN
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81773740, 81073119]; Science and Technology Plan Project of Guangzhou City [201804010027]

作者

  • Z

    Zou, Binhua (第一作者)

    new · southern med univ

  • Z

    Zheng, Jiehuang

    new · southern med univ

查看全部 12 位作者收起作者
  • D

    Deng, Wende

    new · southern med univ

  • T

    Tan, Yanhui

    new · southern med univ

  • J

    Jie, Ligang

    southern med univ

  • Q

    Qu, Yuan

    southern med univ

  • Y

    Yang, Qin

    new · southern med univ

  • K

    Ke, Minhong

    new · southern med univ

  • D

    Ding, Zongbao

    new · southern med univ

  • C

    Chen, Yan

    new · southern med univ

  • Y

    Yu, Qinghong (通讯)

    southern med univ

  • L

    Li, Xiaojuan (通讯)

    new · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417